Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Single Arm Phase IIb Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer

NCT06866938 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT06866938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06866938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Single Arm Phase IIb Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer
Lead sponsor
Hospices Civils de Lyon
Phase
Phase 2
Overall status
Recruiting
Start date
April 11, 2025
Completion date
April 30, 2030
Enrollment
58 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer